A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma
Clinical trial NCT05840289 · UNKNOWN
Trial details
- NCT number
- NCT05840289
- Sponsor
- University Hospital, Geneva
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-24
- Primary completion
- 2023-05-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.